Institutional investors hold a majority ownership of MRK through the 75.42% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 6.9 Million shares of Merck
NORDEA INVESTMENT MANAGEMENT AB ... Bought 5.2 Million shares of Merck
THE VANGUARD GROUP, INC. Bought 3.3 Million shares of Merck